New perspectives on the pharmacotherapy of ischemic stroke

Chemical Compounds

• Antithrombocytic Agent 100%
• Clopidogrel 52%
• Thrombotic 52%
• Anticholesteremic Agent 52%
• Dipyridamole 50%
• Antihypertensive Agent 49%
• Warfarin 45%
• Anticoagulant Agent 43%
• Blood Pressure 43%
• Anticoagulant 41%
• Drug 35%
• Cholesterol 30%
• Pharmaceutical 24%

Medicine & Life Sciences

• Stroke 46%
• Drug Therapy 40%
• Secondary Prevention 15%
• Clopidogrel 12%
• Platelet Aggregation Inhibitors 11%
• Transient Ischemic Attack 11%
• Dipyridamole Drug Combination Aspirin 9%
• Atrial Fibrillation 9%
• Cholesterol 7%
• Hypertension 6%
• Brain Infarction 6%
• Hemiplegia 6%
• Cerebral Arteries 6%
• Tissue Plasminogen Activator 5%
• Literature 5%
• Warfarin 5%
• Cerebrovascular Disorders 5%
• Primary Prevention 5%
• Embolism 5%
• Neurologic Manifestations 5%
• Brain Ischemia 5%
• Therapeutics 5%
• Dyslipidemias 5%
• Anticoagulants 4%
• Aspirin 4%
• Antihypertensive Agents 4%
• Information Storage and Retrieval 4%
• Pharmaceutical Preparations 4%
• Life Style 4%
• Language 4%
• Thrombosis 4%
• Smoking 3%
• Randomized Controlled Trials 3%
• Recurrence 3%
• Wounds and Injuries 2%